Biotech Stocks

Four questions on new safety warnings for Neurocrine’s Vykat XR

Endpoints News 1h ago

A group of experts on Prader-Willi syndrome has sounded the alarm on side effects and deaths that may be connected to Neurocrine Biosciences’ medicine Vykat XR. The treatment has been linked to seven deaths, largely ...

Discussion

Sign in to join the discussion. Comments loading…